These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2529764

  • 1. Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure.
    Carlone S, Palange P, Mannix ET, Salatto MP, Serra P, Weinberger MH, Aronoff GR, Cockerill EM, Manfredi F, Farber MO.
    Am J Med Sci; 1989 Oct; 298(4):243-8. PubMed ID: 2529764
    [Abstract] [Full Text] [Related]

  • 2. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T, Ogino K, Kitamura H, Saitoh M, Omodani H, Osaki S, Hisatome I, Miyakoda H.
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [Abstract] [Full Text] [Related]

  • 3. The effect of oxygen with exercise on atrial natriuretic peptide in chronic obstructive lung disease.
    Mannix ET, Manfredi F, Palange P, Aronoff GR, Weinberger MH, Farber MO.
    Chest; 1992 Feb; 101(2):341-4. PubMed ID: 1531190
    [Abstract] [Full Text] [Related]

  • 4. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
    Selçuk Y, San A, Bakan E, Yiğitoğlu R.
    Nephrol Dial Transplant; 1991 Feb; 6(8):557-61. PubMed ID: 1835523
    [Abstract] [Full Text] [Related]

  • 5. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects.
    Portaluppi F, Bagni B, degli Uberti E, Montanari L, Cavallini R, Trasforini G, Margutti A, Ferlini M, Zanella M, Parti M.
    J Hypertens; 1990 Jan; 8(1):85-95. PubMed ID: 2157761
    [Abstract] [Full Text] [Related]

  • 6. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
    Colantonio D, Casale R, Desiati P, Giandomenico G, Bucci V, Pasqualetti P.
    J Clin Pharmacol; 1991 Mar; 31(3):238-42. PubMed ID: 1826912
    [Abstract] [Full Text] [Related]

  • 7. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A, Kubo S, Hirota Y, Kawamura K, Takatsu T.
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [Abstract] [Full Text] [Related]

  • 8. Renin-aldosterone system and atrial natriuretic peptide during anesthesia in orthopedic patients over 80 years of age.
    Kudoh A, Ishihara H, Matsuki A.
    J Clin Anesth; 1999 Mar; 11(2):101-7. PubMed ID: 10386279
    [Abstract] [Full Text] [Related]

  • 9. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T, Endo A, Kato M, Kato T, Ahmmed GU, Omodani H, Osaki S, Ogino K, Hisatome I, Miyakoda H, Fujimoto Y, Yoshida A, Shigemasa C.
    Cardiology; 1997 Mar; 88(3):238-45. PubMed ID: 9129844
    [Abstract] [Full Text] [Related]

  • 10. [Atrial natriuretic peptide and plasma renin activity in patients with stable chronic obstructive pulmonary disease].
    Nakano T, Yamamoto T, Iwahashi N, Maeda J, Hada T, Higashino K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):20-7. PubMed ID: 1385634
    [Abstract] [Full Text] [Related]

  • 11. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome.
    Hwang SJ, Tsai JH, Lai YH, Chen JH.
    Nephron; 1991 Jan; 58(3):330-8. PubMed ID: 1832746
    [Abstract] [Full Text] [Related]

  • 12. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW, Schunkert H, Muders F, Elsner D, Kuch B, Hense HW, Riegger GA.
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [Abstract] [Full Text] [Related]

  • 13. Atrial natriuretic peptide and the renin-aldosterone axis during exercise in man.
    Mannix ET, Palange P, Aronoff GR, Manfredi F, Farber MO.
    Med Sci Sports Exerc; 1990 Dec; 22(6):785-9. PubMed ID: 2149582
    [Abstract] [Full Text] [Related]

  • 14. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
    Lee ME, Miller WL, Edwards BS, Burnett JC.
    J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
    [Abstract] [Full Text] [Related]

  • 15. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
    van den Berg MP, Tjeerdsma G, Jan de Kam P, Boomsma F, Crijns HJ, van Veldhuisen DJ.
    Eur J Heart Fail; 2002 Jun; 4(3):255-62. PubMed ID: 12034149
    [Abstract] [Full Text] [Related]

  • 16. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J, Abraham WT, Dürr JA, Schrier RW.
    Am J Nephrol; 1991 Jun; 11(6):441-6. PubMed ID: 1840232
    [Abstract] [Full Text] [Related]

  • 17. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
    Sergev O, Rácz K, Varga I, Kiss R, Fütö L, Gutkowska J, Gláz E.
    Clin Exp Hypertens A; 1991 Jun; 13(3):409-23. PubMed ID: 1832596
    [Abstract] [Full Text] [Related]

  • 18. The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome.
    Pasqualetti P, Casale R.
    Riv Eur Sci Med Farmacol; 1996 Jun; 18(4):137-41. PubMed ID: 9177611
    [Abstract] [Full Text] [Related]

  • 19. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
    Stevens TL, Burnett JC, Kinoshita M, Matsuda Y, Redfield MM.
    J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
    [Abstract] [Full Text] [Related]

  • 20. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G, Schittenhelm U, Bönner G, Kaufmann W.
    Cardiology; 1989 Mar; 76(6):418-27. PubMed ID: 2558792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.